Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash Flows From Operating Activities:
Net income (loss)	$ 670,222	$ (670,823)
Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:
Depreciation and amortization expense	678,010	637,225
Gain on tax settlement	(443,110)	0
Gain on plant acquisition	(1,500,000)	0
Amortization of debt discount	63,360	70,242
Accretion of asset retirement obligation	4,611	4,342
Common stock payable for directors fees	131,250	131,250
Foreign exchange (gain) loss	0	49,000
Other non cash items	(681)	(682)
Change in:
Accounts receivable, net	(211,637)	55,722
Inventories	197,813	(84,243)
Other current assets	4,697	(790)
Other assets	(91,592)	(83,437)
Accounts payable	28,619	402,207
Accrued payroll, taxes and interest	(49,984)	(50,862)
Deferred revenue	(27,649)	0
Other accrued liabilities	161,486	30,305
Payables to related parties	33,669	1,797
Net cash provided (used) by operating activities	(350,916)	491,253
Cash Flows From Investing Activities:
Purchase of properties, plants and equipment	(411,571)	(279,465)
Proceeds from plant acquisition	1,500,000	0
Net cash provided (used) by investing activities	1,088,429	(279,465)
Cash Flows From Financing Activities:
Net proceeds from (payments to) factor	5,168	13,338
Checks issued and payable	13,572	12,726
Advance from related party	125,000	0
Payment on advances from related party	(125,000)	0
Principal payments on notes payable to bank	(92,565)	(64,291)
Principal payments on long-term debt	(178,504)	(156,042)
Net cash provided (used) by financing activities	(252,329)	(194,269)
NET INCREASE IN CASH AND CASH EQUIVALENTS	485,184	17,519
Cash and cash equivalents and restricted cash at beginning of period	91,332	73,332
Cash and cash equivalents and restricted cash at end of period	576,516	90,851
Noncash investing and financing activities:
Common stock payable issued to directors	$ 175,000	$ 168,750